CONCOMITANT IMMUNITY AND ITS INFLUENCE ON TUMOUR METASTASING
Main researcher
: ANDREIS, IGOR (496) Assistants
TARADI, MILAN (49133)
KOZJEK, LIDIJA (123743)
Type of research: basic Duration from: 01/01/91. to 12/31/94. Papers on project (total): 4
Institution name: Medicinski fakultet, Zagreb (108) Department/Institute: Department of physiology Address: Šalata 3, PO Box 978 City: 10000 - Zagreb, Croatia
Communication
Phone: 385 (0)041-466-766
Summary: - Concomitantly immune splenocytes can adoptively transfer
immunity to EAT; splenocytes from period of weakening of concomitant
immunity (CI) (16th day) prevent the effects of adoptive immunotherapy. -
The growth dynamics of the subcutaneously (sc) growing secondary tumour
has shown no significant difference when comparred with intraperitoneally
(ip) growing secondary tumour; moreover, sc growing tumour enables more
precise follow-up of tumour growth. - Injection of Cyclophosphamide (Cy)
(200 mg/kg) in animals which 13 or 15 days bear primary tumour (that is, 1
or 3 days before secondary tumor implantation) suppressed the secondary
tumour growth; these results indicate that suppressor lymphocytes might be
responsible for weakening of CI. - Neutralization test has shown that
inhibitory effect of splenocytes from mice that bear primary tumour 20
days could not be abolished by Cy; in this case it seems that some other
cells (possibly macrophages) are responsible for weakening of CI. - Both
macrophages and lymphocytes are responsible for antitumor effect in the
period of maximally expresed CI, but effect of lymphocytes is more
expressed. - The results indicate the prevalence of suppressor T cells in
early period of weakening of CI and of macrophages prevalence in the late
period. - The number of lung metastases after iv injection of mammary
carcinoma cells and of concomitant immune splenocytes in different
intervals before and after tumor inoculation was the lowest when
splenocytes were injected 1 or 3 days before tumor cells.
Research goals: The main purpose of submitted project was to
investigate the factors influencing the tumor concomitant immunity (CI)
dynamics, specially studying the causes and mechanisms of CI weakening or
disappearance. The most part of the work was directed to the relationship
between CI and tumour metastasing. It is, namely, believed that weakening
or disappearance of CI enables tumour metastases to appear and grow.
Because the secondarily transplanted tumour can be considered an arteficial
metastasis, the investigation od CI dynamics could be useful for
understanding of metastasing mechanisms. Moreover, elimination of causes of
CI weakening could delay the metastases appearance. The submitted
investigations have not only theoretical importance, because they could
contribute to explanation of circumstances in which tumour metastases
appear. Other information about the project.